We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Dr Martens plc (DOCS) ORD GBP0.01

Sell:72.05p Buy:72.40p 0 Change: 2.10p (2.82%)
FTSE 250:0.23%
Market closed Prices as at close on 16 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 2.10p (2.82%)
Market closed Prices as at close on 16 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 2.10p (2.82%)
Market closed Prices as at close on 16 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels, and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion, and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.

Contact details

28 Jamestown Rd, Camden
United Kingdom
+ (0)

Important dates

Future events
Final ex-dividend date 29 August 2024 29/08/24
Past events
AGM 11 July 2024 11/07/24
Trading Announcement 11 July 2024 11/07/24
Annual report 12 June 2024 12/06/24
Final results 30 May 2024 30/05/24
Trading Announcement 16 April 2024 16/04/24
Interim dividend payment date 02 February 2024 02/02/24
Trading Announcement 25 January 2024 25/01/24
Interim ex-dividend date 04 January 2024 04/01/24
Interim results 30 November 2023 30/11/23
Final dividend payment date 18 July 2023 18/07/23

General stock information

Market cap:
£695.24 million
Shares in issue:
961.61 million
No specific Industry
London Stock Exchange
Sterling pence
FTSE 250,FTSE 350,FTSE All Share,FTSE 350 Higher Yield

Key personnel

  • Kenny Wilson
    Chief Executive Officer, Executive Director
  • Giles Wilson
    Chief Financial Officer, Executive Director
  • Derek Chan
    President, APAC
  • Jennifer Somer
    President, Americas
  • Mike Stopforth
    President, EMEA
  • Geert Peeters
    Chief Operating Officer
  • Bridget Jolliffe
    Chief People Officer
  • Graham Calder
    Chief Technology Officer
  • Adam Meek
    Chief Product Officer
  • Ije Nwokorie
    Chief Brand Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.